Drugs / Indium In 111 Anti-CD45 Monoclonal Antibody BC8
Indium In 111 Anti-CD45 Monoclonal Antibody BC8
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01300572 | Jan 2012 → Oct 2017 | acute myeloid leukemia, adult acute lymphoblastic leukemia, chronic myelomonocytic leukemia, myelodysplastic syndrome with excess blasts | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indium In 111 Anti-CD45 Monoclonal Antibody BC8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01300572 ↗ |
| Modality | Monoclonal antibody | “Indium In 111 Anti-CD45 Monoclonal Antibody BC8” NCT01300572 ↗ |
| Route | Intravenous | “Given IV (dosimetric dose)” NCT01300572 ↗ |